India’s Patent Laws Fall Short, Report Claims

Law360, New York (January 19, 2007, 12:00 AM EST) -- In a move that could spur changes to India’s intellectual property laws, an independent panel has called into question a key section of the country’s Patent Act, saying it is not fully in line with international standards.

The panel, headed by Dr. Ragunath Anand Mashelkar, Director-General of India’s Council of Scientific and Industrial Research, was tasked with determining whether limiting patent grants for pharmaceutical substances to new chemical entities (NCEs) is compatible with India’s obligations under Trade Related Aspects of Intellectual Property Rights (TRIPS).

Intellectual property...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.